Meeting
2023 ASCO Annual Meeting
Updated molecular analysis of MET exon 14 skipping mutations (METex14) in non-small cell lung cancer (NSCLC).
Authors
Jennifer Aline Marks
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC
Jennifer Aline Marks , Nishant Gandhi , Balazs Halmos , Suresh S. Ramalingam , Lyudmila Bazhenova , Melina Elpi Marmarelis , Joanne Xiu , Phillip Walker , Matthew James Oberley , Patrick C. Ma , Stephen V. Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9095)
DOI
10.1200/JCO.2023.41.16_suppl.9095
Abstract #
9095
Poster Bd #
83
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The impact of PD-L1 expression and co-mutations on outcome of KRAS-driven non-small-cell lung cancer.
First Author: Petros Christopoulos
Poster
2022 ASCO Annual Meeting
Analysis of MET exon 14 skipping mutations in non–small cell lung cancer (NSCLC) by histology and specific mutation.
First Author: Jennifer Aline Marks
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2018 ASCO Annual Meeting
Concurrent genomic alterations in lung adenocarcinoma with a MET exon 14 skipping mutation.
First Author: Julia Rotow